Press release from Companies: WntResearch slutför fas-1-studien med Foxy-5 och initierar fas 1b-studie

Press release from Companies: WntResearch slutför fas-1-studien med Foxy-5 och initierar fas 1b-studie

Press release from Companies: WntResearch slutför fas-1-studien med Foxy-5 och initierar fas 1b-studie

More from the company: Recently published pre-clinical data suggest that Wnt-5a can promote cancer progression in oral squamous carcinoma

More from the company: Recently published pre-clinical data suggest that Wnt-5a can promote cancer progression in oral squamous carcinoma

More from the company: Recently published pre-clinical data suggest that Wnt-5a can promote cancer progression in oral squamous carcinoma

More from the company: Nyligen publicerade prekliniska data tyder på att Wnt-5a kan främja progression av oral skivepitelial cancer

More from the company: Nyligen publicerade prekliniska data tyder på att Wnt-5a kan främja progression av oral skivepitelial cancer

More from the company: Nyligen publicerade prekliniska data tyder på att Wnt-5a kan främja progression av oral skivepitelial cancer

Press release from Companies: The European patent office intends to grant a patent covering WntResearch’s Foxy-5

Press release from Companies: The European patent office intends to grant a patent covering WntResearch’s Foxy-5

Press release from Companies: The European patent office intends to grant a patent covering WntResearch’s Foxy-5